Abbott | ABT - Trade Debtors


Abbott reported $11.22B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
Agilent USD 1.5B 23M Mar/2026
AtriCure USD 79.98M 8.67M Jun/2026
Baxter International USD 1.86B 158M Jun/2026
Becton, Dickinson and Co. USD 2.36B 159M Jun/2026
Bio-Rad Laboratories USD 441.8M 15.6M Jun/2026
Boston Scientific USD 3.03B 101M Mar/2026
Cooper Companies USD 809.2M 2.1M Mar/2026
Danaher USD 4.96B 205M Jun/2026
Dexcom USD 1.27B 175.4M Jun/2026
Edwards Lifesciences USD 973M 60.9M Mar/2026
Globus Medical USD 739.28M 3.84M Jun/2026
Insulet USD 588.7M 44M Jun/2026
Integra LifeSciences USD 267.19M 2.78M Jun/2026
Intuitive Surgical USD 1.67B 77.6M Jun/2026
J&J USD 22.54B 1.21B Mar/2026
Medtronic USD 6.36B 30M Dec/2025
Merit Medical Systems USD 250.9M 23.9M Jun/2026
Pfizer USD 16.19B 19M Jun/2026
Smith & Nephew USD 1.52B 36M Jun/2026
Solventum Corp USD 1.69B 346M Jun/2026
Stryker USD 3.74B 172M Jun/2026
Tandem Diabetes Care USD 162.06M 21.39M Jun/2026
Teleflex USD 364.61M 917K Jun/2026
Terumo JPY 225.57B 8B Jun/2026
Thermo Fisher Scientific USD 9.45B 247M Jun/2026
Zimmer Biomet Holdings USD 1.77B 40.9M Jun/2026